You are here

Genentech

Genentech aims high with new diversity goals, including doubling hires and spending $1B with diverse suppliers

Fierce Pharma

Thu, 04/1/21 - 11:37 pm

Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll

Fierce Pharma

Thu, 03/18/21 - 11:01 am

Horizon Therapeutics

employee satisfaction

Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom

Endpoints

Mon, 03/15/21 - 10:50 am

GenMark Diagnostics

FDA Approves First Biologic for Rare, Debilitating Lung Disease

BioSpace

Sun, 03/7/21 - 01:35 pm

Genentech teams with academics for 10-year neuroscience R&D push

Fierce Biotech

Sun, 02/28/21 - 10:12 pm

Genentech Could Regain the Blindness-Related Disease Market with New Treatment

BioSpace

Sat, 02/13/21 - 11:01 pm

clinical trials

age-related macular degeneration

Why ipatasertib is not the Akt Astra wants to follow

EP Vantage

Thu, 02/4/21 - 10:39 am

triple negative breast cancer

Roche and Genentech's latest AI collaborator raises $25M Series A to reinvent one of the oldest cancer targets

Endpoints

Wed, 02/3/21 - 10:50 am

artificial intelligence

machine learning

JPM Week: Genentech CEO says partnerships, speedier trials among pandemic's 'silver linings'

Fierce Pharma

Mon, 01/11/21 - 07:03 pm

Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling

Fierce Biotech

Mon, 01/11/21 - 10:30 am

Atalanta Therapeutics

neurodegenerative disease

Genentech Launches $1B+ RNA Collaboration with Ribometrix

Genetic Engineering News

Wed, 01/6/21 - 11:27 pm

small molecule drugs

Genentech pays Relay $75M for cancer drug, plans KRAS combo

Fierce Biotech

Mon, 12/14/20 - 11:07 am

Relay Therapeutics

KRAS inhibitors

A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline

Endpoints

Wed, 12/2/20 - 10:43 am

artificial intelligence

Growing Opportunities – The Latest Job Expansions in the Life Sciences Industry

BioSpace

Tue, 12/1/20 - 11:01 am

Revance Therapeutics

Cold Chain Technologies

August Bioservices

FDA approves Roche’s Xofluza to prevent flu spreading in families

Pharmaforum

Tue, 11/24/20 - 10:26 am

FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar

Pharmaforum

Thu, 11/19/20 - 10:33 am

Samsung Bioepis

Roche's James Sabry inks his second AI deal in back-to-back pacts — this time partnering Genentech with Stanford spinout Genesis Therapeutics

Endpoints

Mon, 10/19/20 - 11:07 pm

artificial intelligence

drug development

Genesis Therapeutics

FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies

Pharmaforum

Mon, 10/19/20 - 10:56 am

clinical trials

Months after retiring from Genentech, Michael Varney brings his drug hunting eye to Frazier

Endpoints

Tue, 10/13/20 - 11:18 am

Frazier Healthcare

Genentech pays $200M for Vaccibody's phase 1 cancer vaccine

Fierce Biotech

Thu, 10/1/20 - 10:05 am

cancer vaccines

Pages